Three decades ago, cancer biologists embraced an elegant idea known as the sphingosine rheostat: a molecular dial inside ...
A new review proposes that the ratio of monounsaturated to polyunsaturated membrane phospholipids acts as a tunable rheostat ...
St. Jude Children's Research Hospital scientists have determined how a protein's disordered region serves as a molecular rheostat to help regulate cell survival. The survival drama is played out ...
Synthetic biochemistry seeks to engineer complex metabolic pathways for chemical conversions outside the constraints of the cell. Establishment of effective and flexible cell-free systems requires the ...
Cambridge, Massachusetts-based biotech company Rheostat Therapeutics announced it has raised $23 million in Series A funding to develop potential treatments for neurodegenerative diseases, cognition, ...
Researchers have found a switch that regulates the activity of HNF1A, a gene that causes diabetes. The study highlights potential new vulnerabilities in the disease and could lead to the development ...
Rheostat drew its series A from MRLV, AbbVie Ventures, Amgen Ventures, Alexandria Venture Investments, Mayo Clinic, SV Health Investors and the Dementia Discovery Fund. (Pixabay) Rheostat Therapeutics ...
Rheostat Therapeutics, a young biotech firm focused on treatments for neurodegeneration, cognition, and rare diseases, secured $23 million in its first formal round of funding. Rheostat is developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results